Galmed Pharmaceuticals (NASDAQ:GLMD) Coverage Initiated at StockNews.com
Investment analysts at StockNews.com started coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) in a report released on Sunday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance NASDAQ:GLMD opened at $2.56 on Friday. The stock has a fifty day moving average price of $2.90 and […]
Investment analysts at StockNews.com started coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) in a report released on Sunday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance NASDAQ:GLMD opened at $2.56 on Friday. The stock has a fifty day moving average price of $2.90 and […]
